Overview
Force Therapeutics provides a digital platform that connects orthopedic patients with their care teams to manage recovery outside of the hospital. The platform works by delivering customized daily video content and digital tasks to patients, allowing providers to monitor progress and communicate remotely throughout the entire recovery journey. Unlike many competitors, the company utilizes an extensive research network of over 60 orthopedic centers to ensure its care protocols are based on a decade of clinical evidence. The company’s goal is to improve patient outcomes and reduce healthcare costs by standardizing recovery and extending the reach of medical teams through virtual engagement.
Work here?Claim your company
Simplify's Take
What believers are saying
- CJR-X finalized August 2026 creates a nationwide buying trigger for Force's platform.
- ECU Health, April 23, 2025, shows continued health-system demand for standardized digital pathways.
- Force's 2026 research and AAOS positioning strengthen sales into quality-focused orthopedic centers.
What critics are saying
- CMS can copy its episode-management playbook, compressing pricing after CJR-X starts January 1, 2028.
- Private-market scale looks tiny: PitchBook listed 42 employees in 2025.
- If orthopedic bundles disappoint, hospitals cut subscriptions and Force loses its core wedge.
What makes Force Therapeutics unique
- Force Therapeutics owns orthopedic episode workflows built for CMS bundled payments.
- January 8, 2026 research output reinforces its outcomes-data moat with providers.
- AAOS PROMs Vendor Program recognition, June 4, 2025, validates its clinical credibility.
Help us improve and share your feedback! Did you find this helpful?
